CYP3A4 inducers might enhance the formation in the neurotoxic/nephrotoxic ifosfamide metabolite, chloroacetaldehyde. Intently check clients taking ifosfamide with CYP3A4 inducers for toxicities and consider dose adjustment.Individuals stabilized on corticosteroid therapy may demand dosage adjustments if barbiturates are additional to or withdrawn f